Is Neil Woodford stock Provident Financial plc poised for a monster turnaround?

With its core business trending in the right direction, will 2018 be a year of huge returns for Provident Financial plc (LON: PFG)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s been a bruising few months for Neil Woodford as big stakes in companies as diverse as roadside assistance firm AA to drug-maker Astra Zeneca have turned sour to varying degrees. But perhaps his most high profile bet to go sideways has been on subprime lender Provident Financial (LSE: PFG), whose share price has shrunk by 70% over the past year. But with Woodford still holding a large stake in this business, should retail investors bet on a big turnaround from it in 2018?

Well, the good news is that the company’s core doorstep lending division is making a rebound from a very low base. In December collections performance had increased to 78%, up from 65% in September and 57% in August as the company hired back 300 former self-employed agents on a part-time basis.

Divisional losses still came in at the high end of guidance due to the costs from the tumultuous changes in operating style. But with agents back on the street, the business is moving in the right direction again as new loans are extended and old ones are collected.

Furthermore, with the company now valued at only 7.3 times 2018 consensus earnings, there’s very little possible upside priced into its shares. Unfortunately, I believe this negativity may be warranted as the Financial Conduct Authority continues its investigation into the group’s highly profitable Vanquis credit card arm and has recently opened one into its Moneybarn auto loan division.

When the FCA opened an investigation “in relation to the processes applied to customer affordability assessments for vehicle finance and the treatment of customers in financial difficulties,” I saw reason to be nervous. It makes me believe similar issues may be lurking in other parts of the business, or at the very least that the FCA will be poking around to find them.

While I’ve long backed Provident due to its market-leading position, ability to build profitable growth throughout the economic cycle and return gobs of cash to shareholders, the combination of self-inflicted operational problems and heightened regulatory scrutiny is enough to stop me from using this opportunity to begin a stake in the business.

Growth and dividends at a low price

One Woodford holding that’s run into problems but is far more interesting to me is Card Factory (LSE: CARD). The company warned in October that it would experience little-to-no EBITDA growth for the year as it decided to absorb the costs of input and wage inflation rather than pass these on to customers.

While flat profits aren’t great, I believe this period gives it the chance to accelerate its market share gains at the expense of rivals, who unlike Card Factory don’t own their own manufacturing and thus have much higher costs.

Indeed, this process is already occurring with it posting like-for-like growth of 2.7% in the 11 months to December and total sales growth of 5.9% due to new store openings. With management targeting 50 new stores a year and same-store sales growth accelerating, I believe Card Factory’s decision will be vindicated as it pushes competitors out of the market.

This growth potential alongside industry-leading margins, low debt, a 4.65% dividend yield and low valuation of just 10.7 times forward earnings make this one Woodford holding I’d love to own for the long term.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Could this cheap FTSE 100 stock be the next Rolls-Royce?

Paul Summers casts his eye over a battered-but-high-quality FTSE 100 stock. Is this the next top-tier company to stage a…

Read more »

ISA Individual Savings Account
Investing Articles

Hesitant over a Stocks and Shares ISA? Here’s a way to deal with scary markets

Volatile stock markets are scaring potential investors away from getting started with their first Stocks and Shares ISA in 2026.

Read more »

This way, That way, The other way - pointing in different directions
Market Movers

Standard Life’s announced a £2bn deal but its share price is largely unchanged. Why?

James Beard considers why the Standard Life share price didn’t take off today (15 April) after the group announced it…

Read more »

Happy parents playing with little kids riding in box
Investing Articles

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

This 5%-yielding dividend stock was one of the top performers in the FTSE 250 index today. What sent it flying…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Young investors are taking the stock market on a rollercoaster ride. Here’s how retirees can buckle up

Mark Hartley reveals the volatile impact that younger investors are having on the stock market and how UK retirees can…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

£7,500 invested in Aviva shares 5 years ago is now worth…

A lump sum pumped into Aviva shares half a decade ago has grown a lot. Andrew Mackie looks at the…

Read more »

Young female hand showing five fingers.
Investing Articles

Could £20,000 invested in these 5 dividend shares produce £14,760 of passive income over the next 10 years?

James Beard considers the potential of dividend shares to deliver amazing levels of passive income. Here are five that have…

Read more »

Workers at Whiting refinery, US
Investing Articles

At 570p, is it too late to consider buying BP shares?

Since the end of February, when the conflict in the Middle East started, BP shares have soared nearly 20%. But…

Read more »